Europe Microfluidics Market Analysis and Opportunities by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Europe Microfluidics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Microfluidic Chips, Microfluidic Sensors, Devices , Micropumps, Microneedles and Other Products), Material (PDMS, Polymers, Glass, Silicon, and Other Materials), Application (In Vitro Diagnostics, Pharmaceutical and Life Science Research, Drug Discovery, and Other Applications); and Country

  • Report Date : Aug 2020
  • Report Code : TIPRE00013008
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 179
Page Updated: Oct 2020

The Europe microfluidics market was valued at US$ 3,625.15 million in 2019 and is projected to reach US$ 12,827.36 million by 2027; it is expected to grow at a CAGR of 17.4% during 2020–2027.



The growth of the microfluidics market is mainly attributed to the factors such as adoption of microfluidics technologies in point-of-care testing, and advancement in microfluidics products are expected to propel the growth of the market. However, regulatory approval process is the major factor hindering the market growth.

The UK has observed the fastest growth in the Europe microfluidics market within the past few years and is expected to lead the market in Europe during the forecast period. The rising funding and growing technological advancements are counts as a leading contributing factor to market growth in the UK. For instance, a UK based company, MicrofluidX, has closed a US$ 1.8M (€1.6M) seed funding round to develop a microfluidic platform to produce cell and gene therapies more cheaply than conventional cell cultures with current manufacturing techniques. The funding round was headed by UKI2S, a national seed investment fund targeting early-stage companies, as well as Longwall Ventures and Cambridge Angels. With this prototype, the company aims to compare the performance of its microfluidics approach to current cell culture techniques used to produce gene and cell therapies. Also, the company is focusing on other areas that scale-up microfluidics far ahead of just biology research.

UK Microfluidics Market Revenue and Forecast to 2027 (US$ Million)

UK Microfluidics Market Revenue and Forecast to 2027 (US$ Million)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE MICROFLUIDICS – MARKET SEGMENTATION

Microfluidics Market – By Product

  • Devices
  • Microfluidic Chips
  • Microfluidic Sensors
  • Micropumps
  • Microneedles
  • Other Products

Microfluidics Market – By Material

  • PDMS
  • Glass
  • Silicon
  • Polymer
  • Other Materials

Microfluidics Market – By Application

  • In Vitro Diagnostics
    • Point-of-Care Testing
    • Clinical Diagnostics
  • Pharmaceutical and Life Science Research
  • Drug Discovery
  • Other Applications

By Country

  • Germany
  • France
  • UK
  • Italy
  • Spain

Company Profiles

  • Agilent Technologies, Inc.,
  • BD
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Dolomite Microfluidics (Blacktrace Holdings Ltd.)
  • Fludigm Corporation
  • Illumina, Inc.
  • microfluidic ChipShop GmbH,
  • Perkin Elmer, Inc.
  • Thermo Fisher Scientific Inc.

Europe Microfluidics Report Scope

Report Attribute Details
Market size in 2019 US$ 3,625.15 Million
Market Size by 2027 US$ 12,827.36 Million
Global CAGR (2020 - 2027) 17.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Microfluidic Chips
  • Microfluidic Sensors
  • Devices
  • Micropumps
  • Microneedles and Other Products
By Material
  • PDMS
  • Polymers
  • Glass
  • Silicon
  • Other Materials
By Application
  • In Vitro Diagnostics
  • Pharmaceutical and Life Science Research
  • Drug Discovery
  • Other Applications
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Agilent Technologies, Inc.,
  • BD
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Dolomite Microfluidics (Blacktrace Holdings Ltd.)
  • Fludigm Corporation
  • Illumina, Inc.
  • microfluidic ChipShop GmbH,
  • Perkin Elmer, Inc.
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo